Menstrual migraines: Etiology, treatment, and relationship to premenstrual syndrome

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 3, 1997, Pages 154-159

  Kornstein, Susan G ^a   Parker, Angelika J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERGOT DERIVATIVE; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN ANTAGONIST;

CORRELATION FUNCTION; FEMALE; HUMAN; MENSTRUAL CYCLE; MIGRAINE; PATHOGENESIS; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0030811564     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199706000-00003     Document Type: Review

References (67)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML: Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992, 267: 64-69.
2. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(suppl):1-96.
3. Johannes CB, Linet MS, Stewart WF, Celentano DD. Lipton RB, Szklo M: Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 1995, 45:1076-1082.
4. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC: Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 1993, 33:385-389.
5. Rasmussen BK, Olesen J: Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 1992, 12:221-228.
6. Cupini LM, Matteis M, Troisi E, Calabresi P, Bernadi G, Silvestrini M: Sex-hormone related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 1995, 15:140-144.
7. Beckham JC, Krug LM, Penzien DB, Johnson CA, Mosley TH Jr, Meeks GR, Pbert LA, Prather RC: The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineurs. Headache 1992, 32:292-297.
8. Silberstein SD: The role of sex hormones in headache. Neurology 1992, 42(suppl 2):37-42.
9. MacGregor EA, Chia H, Vohrah C, Wilkinson M: Migraine and menstruation: a pilot study. Cephalalgia 1990, 10:305-310.
10. Silberstein SD, Merriam GR: Estrogens, progestins, and headache. Neurology 1991, 41:786-793.
11. Silberstein SD: Menstrual migraine. Headache 1992, 32:312-313.
12. Rose FC: Menstrual migraine. Headache 1994, 34:446.
13. Marcus DA: Interrelationships of neurochemicals, estrogen, and • • recurring headache. Pain 1995, 62:129-139. Excellent review of the neuropathology of migraines in general and menstrual migraines in particular.
14. Noack H, Rothrock JF: Migraine: definitions, mechanisms, and • •treatment. South Med J 1996, 89:762-769. Excellent review of the current understanding of the neuropathology of migraine headaches and suggestions for treatment.
15. Fioroni L, Martignoni E, Facchinetti F: Changes of neuroendocrine • axes in patients with menstrual migraine. Cephalalgia 1995, 15:297-300. Discusses relationship of three different neurotransmitter systems (opioid, noradrenergic, and serotonergic) in the pathogenesis of menstrual migraine.
16. Moskowitz MA: Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993, 43(suppl 3):S16-S20.
17. D'Andrea G, Hasselmark L, Cananzi AR, Alecci M, Perini F, Zamberlan F, Welch KMA: Metabolism and menstrual cycle rhythmicity of serotonin in primary headaches. Headache 1995, 35:216-221.
18. Curren DA, Hinterberger H, Lance JW: Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 1965, 88:997-1009.
19. Fog-Moller F, Genefke IK, Bryndum B: Changes in concentration of catecholamines in blood during spontaneous migraine attacks and reserpine-induced attacks. In Current Concepts in Migraine Research. Edited by Greene R. New York: Raven Press; 1978:115-119.
20. Helm-Hylkema HD, Orlebeke JF, Thijssen JH, van Ree J: Effects of behaviour therapy on migraine and plasma beta-endorphin in young migraine patients. Psychoneuroendocrinology 1990, 15:39-45.
21. Anselmi B, Baldi E, Casacci F, Salmin S: Endogenous opioids in the cerebrospinal fluid and blood in idiopathic headache sufferers. Headache 1980, 20:294-299.
22. Della-Bella D, Carenzi A, Casacci F, Anselmi B, Baldi E, Salmon S: Endorphins in the pathogenesis of headache. Adv Neurol 1982, 33:75-79.
23. Fettes I, Gawel M, Kuzniak S, Edmeads J: Endorphin levels in headache syndrome. Headache 1985, 25:37-39.
24. Leone M, Sacerdote P, D'Amico D, Panerai AE, Bussone G: Beta-endorphin concentrations in the peripheral blood mononuclear cells of migraine and tension-type headache patients. Cephalalgia 1992, 12:155-157.
25. Vecsei L, Widerlow E, Ekman R, Kovacs K, Jelencsik I, Bozsik G, Kapoes G: Suboccipital cerebrospinal fluid and plasma concentrations of somastatin, neuropeptide Y and beta-endorphin in patients with common migraine. Neuropeptides 1992, 22:111-116.
26. Forman LJ, Cavalieri T, Estilow S, Tatarian GT: The elevations of immunoreactive beta-endorphins in old male rats related to alterations in dopamine and serotonin. Neurobiol Aging 1990, 11:223-227.
27. Nattero G, Allais G, DeLorenzo C, Benedetto C, Zonca M, Melzi E, Massobrio M: Relevance of prostaglandins in true menstrual migraine. Headache 1989, 29:232-238.
28. Somerville BW: A study of migraine in pregnancy. Neurology 1972, 22:824-828.
29. Epstein MT, Hockaday JM, Hockaday TDR: Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1975, i:543-548.
30. Nagel-Leiby S, Welch KA, Grunfeld S, D'Andrea G: Ovarian steroid levels in migraine with and without aura. Cephalalgia 1990, 10:147-152.
31. Biegon A, Reches A, Snyder L, McEwen BS: Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983, 32:2015-2028.
32. Bereiter DA, Stanford LR, Barker DJ: Hormone-induced enlargement of receptive fields in trigeminal mechano-receptive neurons. II. Possible mechanisms. Brain Res 1980, 184:411-423.
33. Biegon A, McEwen BS: Modulation by estradiol of serotonin 1 receptors in the brain. J Neurosci 1982, 2:199-205.
34. Nattero G, Allais G, DeLorenzo C, Torre E, Ancona M, Benedetto C, Massabrio M: Menstrual migraine: new biochemical and physiological aspects. Headache 1988, 28:103-107.
35. Wehrenberg WB, Wardlow SL, Frantz AG, Ferin M: Beta-endorphin in hypophyseal portal blood: variations throughout the menstrual cycle. Endocrinology 1982, 111:879-881.
36. Chan WY: Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea. Ann Rev Pharmacol Toxicol 1983, 23:131-149.
37. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G: Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991, 31:298-301.
38. Welch KM, Barkley GL, Tepley N, Ramadan NM: Central neurogenic mechanism of migraine. Neurology 1993, 43(suppl 3):S21-S25.
39. Calabresi P, Silvestrini M, Stratta F, Cupini LM, Argiro G, Atzei GP, Bernard G: 1-Deprenyl test in migraine: neuroendocrinological aspects. Cephalalgia 1993, 13:406-409.
40. Bussone G, Boiardi A, La Mantia L, Frediani F, Lamperti E, Peccarisi C, Parati EA, Pasquadibisceglie L: Clinical usefulness of a dopaminergic agonist in headache diagnosis, Int J Clin Pharmacol Res 1986, 6:23-26.
41. Murialdo G, Martignoni E, Maria AD, Bonura ML, Sances G, Bono G, Pollen A: Changes of dopaminergic control of prolactin secretion and in ovarian steroids in migraine. Cephalalgia 1986, 6:43-49.
42. Gordon JH, Diamond BI: Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biol Psychol 1981, 16:365-371.
43. Brun J, Claustrat B, Saddier P, Chazot G: Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 1995, 15:136-139.
44. Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S, Fanciullacci M, Polleri A: Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994, 14:205-209.
45. Facchinetti F, Neri I, Martignoni E, Fioroni L, Nappi G, Genazzani AR: The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993, 13:422-425.
46. Facchinetti F, Fioroni L, Martignoni E, Sances G, Costa A, Genazzani AR: Changes of opioid modulation of the hypothalamo-pituitary-adrenal axis in patients with severe premenstrual syndrome. Psychosom Med 1994, 56:418-422.
47. Facchinetti F, Martignoni E, Fioroni L, Sances G, Genazzani AR: Opioid control of the hypothalmus-pituitary-adrenal axis cyclically fails in menstrual migraine. Cephalalgia 1990, 10:51-56.
48. Facchinetti F: The premenstrual syndrome belongs in the diagnostic criteria for menstrual migraine. Cephalalgia 1994, 14:413-414.
49. Gupta VK: Menstrual migraine is not pathogenetically related to premenstrual syndrome. Cephalalgia 1994, 14:411-414.
50. Johnson SR: Clinician's approach to the diagnosis and management of premenstrual syndrome. Clin Obstet Gynecol 1992, 35:637-657.
51. Silberstein SD, Merriam GR: Menstrual migraine. Del Med J 1991, 63:477-484.
52. Schulman EA, Silberstein SD: Symptomatic and prophylactic treatment of migraine and tension-type headache. Neurology 1992, 42(suppl 2):16-21
53. Lance JW: Treatment of migraine. Lancet 1992, 339:1207-1209.
54. Kim M, Blanchard EB: Two studies of the non-pharmacological treatment of menstrually-related headaches. Headache 1992, 32:197-202.
55. Gauthier JG, Fournier A-L, Roberge C: The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine. Headache 1991, 31:82-90.
56. Giacovazzo M, Gallo MF, Guidi V, Rico R, Scaricabarozzi I: Nimesulide in the treatment of menstrual migraine. Drugs 1993. 46(suppl 1): 140-141.
57. Gallagher RM: Menstrual migraine and intermittent ergonovine therapy. Headache 1989, 29:366-367.
58. D'Alessandro R, Gamberini G, Lozito A. Sacquegna T: Menstrual migraine: intermittent prophylaxis with a timed-release pharmacologic formulation of dihydroergotamine. Cephalalgia 1983, 15(suppl 1):158.
59. Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A: The • efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. Obstet Gynecol 1995, 86:911 -916. First prospective, double-blind, placebo-controlled study demonstrating the efficacy of sumatriptan in patients with menstrual migraine.
60. Solbach MP, Stevenson Waymer R: Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993, 82:769-772.
61. Rubenstein BB: Premenstrual headache relieved by estrogen therapy. J Clin Endocrinol 1942, 2:700-702.
62. Magos AL, Zilkha KJ, Studd JWW: Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatr 1983, 46:1044-1046.
63. De Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ. Bousser MG: Prevention of menstrual migraine by percutaneous oestradiol. BMJ 1986, 293:1540.
64. Smits MG, van der Meer YG, Pfeil JPJM, Rijnierse JJMM, Vos AJM: Perimenstrual migraine: effect of estraderm TTS® and the value of contingent negative variation and enteroceptive temporalis muscle suppression test. Headache 1993, 34:103-106.
65. Lichten EM, Bennett RS, Whitty AJ, Daoud Y: Efficacy of danazol in the control of hormonal migraine. J Reprod Med 1991, 36:419-424.
66. Holdaway IM, Parr CE, France J: Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex. Aust NZ J Obstet Gynaecol 1991, 31:164-165.
67. O'Dea PK, Davis EH: Tamoxifen in the treatment of menstrual migraine. Neurology 1990, 40:1470-1471.